medical device investing Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018
medical device investing Precision Therapeutics Announces Record STREAMWAY System Sales in the First Three Months of 2018
pharmaceutical investing Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray
Precision Therapeutics Forms TumorGenesis Inc. Subsidiary to Focus on the Next Generation of Patient Derived Tumor Models
medical device investing Skyline Medical Opens New European Headquarters to Drive International Sales of the STREAMWAY System
Government approvals secured for the use of Galidesivir as a treatment for Bundibugyo Ebola epidemic in Africa
Alvopetro Announces June Sales Volumes, an Operational Update and Quarterly Natural Gas Pricing Update
